Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs

THE LONG CON

Langan MD

By Michael Lawrence Langan MD 

Ya gotta spend money to make money, am I right?

The payoffs required are enormous, but once they get in, they make tons of money, and jacking the price of drugs to boot.

President Trump promised that he would take care of that and make a deal to roll back drug prices, but then he met with […]

***

businessman-fashion-man-person-1

***

The long con: Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs — Later On

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

***

Advertisements

One Response

  1. Top Five Prescription Drugs by Revenue in 2016

    1. Humira (AbbVie) $16.078 billion
    2. Harvoni (Gilead Sciences) $9.081 billion
    3. Enbrel (Amgen and Pfizer) $8.874 bllion
    4. Rituxan (Roche [Genentech] and Biogen) $8.583 billion
    5. Remicade (Johnson & Johnson and Merck) $7.829 billion

    Source: Genetic Engineering & Biotechnology News

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: